NCT06790992View on ClinicalTrials.gov

Relıabılıty and Valıdıty of the Supıne-to-stand Test Wıth Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

34

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

November 1, 2024

Conditions

Multiple Sclerosis

Trial Locations (1)

27500

SANKO University, Gaziantep

All Listed Sponsors

lead

Sanko University

OTHER

NCT06790992 - Relıabılıty and Valıdıty of the Supıne-to-stand Test Wıth Multiple Sclerosis | Biotech Hunter | Biotech Hunter